Suppression of these surveillance mechanisms in Trim33-deficient cells leads to overt DNA damage and delays tumor development, possibly both by cell-intrinsic effects (increased tumor cell death) and via activation of immune responses. This evidence concerns the gene TRIM33 and neoplasm.